新医改下我国促进罕见病药品可及性的激励政策体系及其影响分析*
赵宇航,黄锐,王青婷,徐家童,张雯雯,龚时薇
Incentive Policy System and Its Impact Analysis on Promoting the Accessibility of Orphan Drugs in China
ZHAO Yuhang,HUANG Rui,WANG Qingting,XU Jiatong,ZHANG Wenwen,GONG Shiwei
医药导报
.
2022, (12): 1771
-1776
.
DOI: 10.3870/j.issn.1004-0781.2022.12.009